Salette Reis

3 weeks ago | tandfonline.com | Filipa Soares |Beatriz Salinas |Salette Reis |Cláudia Nunes

AbstractContext Cancer therapy remains a challenge in healthcare, particularly in the context of triple-negative breast cancer (TNBC), where targeted therapies are still scarce. Objective Addressing this issue, our study explores a novel targeting approach using small extracellular vesicles (sEVs) isolated from cow milk, functionalized with hyaluronic acid (HA) to target the overexpressed cluster of differentiation 44 (CD44) cell surface receptor in TNBC cells.